Valuation: Abbott Laboratories

Market Cap 177B 153B 145B 131B 246B 16,936B 248B 1,726B 664B 8,587B 663B 648B 27,386B P/E 2026 *
28.9x
P/E 2027 * 22.4x
Enterprise Value 200B 174B 164B 149B 279B 19,232B 281B 1,960B 754B 9,752B 753B 736B 31,100B EV / Sales 2026 *
3.99x
EV / Sales 2027 * 3.62x
Free-Float
86.16%
Yield 2026 *
2.52%
Yield 2027 * 2.69%
1 day+0.25%
1 week-3.31%
Current month-7.55%
1 month-8.29%
3 months+15.07%
6 months-5.55%
Current year-18.56%
1 week 101.47
Extreme 101.47
105.19
1 month 101.47
Extreme 101.47
117.34
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
02/09/26 Sell

Controller/Auditor

-27 0.0000%
01/09/26 Tax

Chief Financial Officer

-388 0.0000%
25/08/26 Exercice

Chief Executive Officer

1,196,496 0.0691%
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-3.31%-22.31%+0.29% 177B
-0.05%+1.47%+0.34%+14.65% 120B
-0.90%-0.43%+10.94%+81.33% 61.69B
+1.65%+3.81%+0.10%-29.51% 50.64B
+0.27%-3.53%+3.35%+39.11% 48.16B
+2.09%+2.27%+14.38%-10.28% 32.62B
-1.47%-7.44% - - 28.17B
+2.76%+8.07%+41.73%-7.40% 25.69B
+0.07%-1.06%-10.97%+3.77% 21.33B
-1.58%-3.74%-15.14%-8.37% 20.5B
Average +0.70%-1.47%+2.49%+9.29% 58.53B
Weighted average by Cap. +0.39%-1.33%-3.70%+11.84%

Financials

2026 *2027 *
Net sales 50.2B 43.49B 41.12B 37.23B 69.87B 4,816B 70.4B 491B 189B 2,442B 189B 184B 7,788B 54.53B 47.23B 44.66B 40.43B 75.89B 5,231B 76.46B 533B 205B 2,652B 205B 200B 8,458B
Net income 6.3B 5.46B 5.16B 4.67B 8.77B 605B 8.84B 61.61B 23.7B 307B 23.68B 23.15B 978B 7.98B 6.91B 6.53B 5.92B 11.1B 765B 11.19B 77.98B 30B 388B 29.97B 29.3B 1,237B
Net Debt 23.94B 20.74B 19.61B 17.75B 33.32B 2,296B 33.57B 234B 90.02B 1,164B 89.92B 87.93B 3,713B 20.96B 18.15B 17.17B 15.54B 29.17B 2,010B 29.39B 205B 78.81B 1,019B 78.72B 76.98B 3,251B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
15/09/26 US$102.03 -1.03% 7,419,476
14/09/26 US$103.09 +1.12% 7,792,131
11/09/26 US$101.95 -1.36% 8,398,311
10/09/26 US$103.36 -1.78% 7,845,268
09/09/26 US$105.23 -0.27% 6,470,872
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
102.03USD
Average target price
120.26USD
Spread / Average Target
+17.87%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!